Esphera SynBio
PrivateLast Round
Seed
Jan 7, 2025
Total Funding Raised
$2M
Momentum Score
50 /100
Company Overview
Esphera SynBio Inc. is a biotechnology company developing next-generation cancer and immunoregulatory treatments through its innovative synthetic biology platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Esphera SynBio Comps
Public and private peers based on sector, stage, and business model.
Esphera SynBio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jan 7, 2025 |
Esphera SynBio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| FACIT | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 7, 2025
$2M raised in Seed round.
Esphera SynBio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Esphera SynBio's valuation, stock price, and market status.
